中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
15期
26-27,28
,共3页
非洛地平%阿托伐他汀%高血压
非洛地平%阿託伐他汀%高血壓
비락지평%아탁벌타정%고혈압
Felodipine%Atorvastatin%Hypertension
目的:探究分析非洛地平联合阿托伐汀对于高血压合并高胆固醇血症的临床治疗效果。方法:选择本辖区内轻中度高血压合并高胆固醇血症患者,进行6个月观察。前3个月给予5 mg/d的非洛地平缓释片,治疗观察期间控制患者的脂肪摄入量、鼓励患者增加体育锻炼。3个月后,在原治疗基础上每日添加服用20 mg的阿托伐他汀。记录患者治疗前、治疗3个月后及6个月后的心率、血压及血脂水平。结果:3个月后患者的SBP值和DBP值均呈下降趋势,但血脂等变化不大。6个月以后,患者SBP值较3个月前明显下降,但DBP值变化不明显,而TC、HDL-C/TC较治疗前差异均有统计学意义(P<0.05)。心率治疗前后变化不明显。结论:临床上应用阿托伐他汀钙片可以很好调节血脂水平,与非洛地平联合运用后可以强化其降血压的效果。非洛地平联合阿托伐他汀治疗高血压合并高胆固醇血症疗效确切。
目的:探究分析非洛地平聯閤阿託伐汀對于高血壓閤併高膽固醇血癥的臨床治療效果。方法:選擇本轄區內輕中度高血壓閤併高膽固醇血癥患者,進行6箇月觀察。前3箇月給予5 mg/d的非洛地平緩釋片,治療觀察期間控製患者的脂肪攝入量、鼓勵患者增加體育鍛煉。3箇月後,在原治療基礎上每日添加服用20 mg的阿託伐他汀。記錄患者治療前、治療3箇月後及6箇月後的心率、血壓及血脂水平。結果:3箇月後患者的SBP值和DBP值均呈下降趨勢,但血脂等變化不大。6箇月以後,患者SBP值較3箇月前明顯下降,但DBP值變化不明顯,而TC、HDL-C/TC較治療前差異均有統計學意義(P<0.05)。心率治療前後變化不明顯。結論:臨床上應用阿託伐他汀鈣片可以很好調節血脂水平,與非洛地平聯閤運用後可以彊化其降血壓的效果。非洛地平聯閤阿託伐他汀治療高血壓閤併高膽固醇血癥療效確切。
목적:탐구분석비락지평연합아탁벌정대우고혈압합병고담고순혈증적림상치료효과。방법:선택본할구내경중도고혈압합병고담고순혈증환자,진행6개월관찰。전3개월급여5 mg/d적비락지평완석편,치료관찰기간공제환자적지방섭입량、고려환자증가체육단련。3개월후,재원치료기출상매일첨가복용20 mg적아탁벌타정。기록환자치료전、치료3개월후급6개월후적심솔、혈압급혈지수평。결과:3개월후환자적SBP치화DBP치균정하강추세,단혈지등변화불대。6개월이후,환자SBP치교3개월전명현하강,단DBP치변화불명현,이TC、HDL-C/TC교치료전차이균유통계학의의(P<0.05)。심솔치료전후변화불명현。결론:림상상응용아탁벌타정개편가이흔호조절혈지수평,여비락지평연합운용후가이강화기강혈압적효과。비락지평연합아탁벌타정치료고혈압합병고담고순혈증료효학절。
Objective:To explore and analysis the clinical effect of Felodipine joint Atorvastatin in the treatment of hypertension complicated with hypercholesterolemia.Method: Patients with mild to moderate hypertension and hypercholesterolemia in our area were selected to be observed for six months. Patients were given daily oral 5 mg of Felodipine tablets for the first 3 months.During the treatment observation period,the fat intake of patients was controlled and patients were encouraged to increase physical activity. Three months later,adding daily doses of Atorvastatin 20 mg based on the original treatment.HR,BP,blood lipid of the patients were recorded before treatment,3 months and 6 months after the treatment.Result:After 3 months, the SBP and DBP values declined,but the blood lipid changed little. 6 months later, SBP values were significantly lower than that three months ago, but DBP values did not change significantly.TC and HDL-C/TC were compared with before, the differences were statistically significant(P<0.05).The HR did not change significantly.Conclusion:Atorvastatin calcium tablets can clinically well regulate lipid levels and strengthen its effect on hypotensive after joint use with Felodipine.